Back to search
FDAFDA · Food and drugs·Recall number D-050-2013

Tobramycin Ophthalmic Oint., 0.3%, 5ml bottle, (Generic for: Tobrex), Rx only, Sterile, Mfg By Akorn, Inc., Lake Forest, IL 60045, NDC 16590-224-05,

Published November 21, 2012 · Recall initiated: June 18, 2012

Summary

FDA records drug Class III recall D-050-2013, published November 21, 2012 and initiated June 18, 2012. Recalling firm: Stat Rx USA; Status: Terminated; Reported quantity: 22 units; Lot: Lot 06JN1265 Exp 3/14 and 06JN1266 Exp 4/14. Class III means the product is not likely to cause adverse health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Labeling: Label Mix-up: The affected units were labeled incorrectly describing the product as "ointment" instead of "solution."

What to do

Voluntary: Firm initiated · E-Mail

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Stat Rx USA
Distributor
FL, PA, and VA.
Lot
Lot 06JN1265 Exp 3/14 and 06JN1266 Exp 4/14
Risk classification
Class III
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Tobramycin Ophthalmic Oint., 0.3%, 5ml bottle, (Generic for: Tobrex), Rx only, Sterile, Mfg By Akorn, Inc., Lake Forest, IL 60045, NDC 16590-224-05, recalled?

Yes. FDA published recall D-050-2013 on November 21, 2012. Reported hazard: Labeling: Label Mix-up: The affected units were labeled incorrectly describing the product as "ointment" instead of "solution."

What should I do if I have this product?

Voluntary: Firm initiated · E-Mail